MedStar Firefighters' Burn and Surgical Laboratory Supports Development of ReCell and Other Skin Regeneration Technologies
Marketwire Canada - Fri Jul 29, 7:26AM CDT
WASHINGTON, DC--(Marketwired - July 29, 2016) - As part of a multicenter clinical research study, the Firefighters' Burn and Surgical Laboratory at MedStar Washington Hospital Center is helping to test the effectiveness of an investigational device called ReCell® by Avita Medical that enables clinicians to harvest skin cells from small sections of a patient's own healthy donor skin, yielding a potential treatment for skin regeneration in a burn injury area up to 80 times the size of the piece of donor skin. The product aims to improve upon traditional skin grafting and meshing techniques by providing coverage to a larger wound area and achieving better long-term scar outcomes, while using a smaller piece of donor skin.
Avita Medical Announces Financial Results for Fourth Quarter Fiscal 2016
Marketwire Canada - Thu Jul 28, 11:00PM CDT
NORTHRIDGE, CA and PERTH, AUSTRALIA and CAMBRIDGE, UNITED KINGDOM--(Marketwired - Jul 29, 2016) - Avita Medical Ltd. (ASX: AVH), (OTCQX: AVMXY), a regenerative medicine company specializing in the treatment of wounds and skin defects, today announced its financial results and business update for the fourth quarter of fiscal 2016 which concluded on June 30, 2016.
AVH: 6.47 (-0.09)
Avita Medical to Present at Global Chinese Financial Forum
Marketwired - Wed Jun 22, 1:15PM CDT
NORTHRIDGE, CA and PERTH, AUSTRALIA and CAMBRIDGE, UNITED KINGDOM--(Marketwired - Jun 22, 2016) - Avita Medical Ltd (ASX: AVH), (OTCQX: AVMXY), a regenerative medicine company specializing in new treatments for wounds and skin defects, today announced that it will present on its commercial strategy in China at the Global Chinese Financial Forum 23 June 2016 in Shanghai.
AVH: 6.47 (-0.09)
Avita Medical Signs Deal for Distribution in Malaysia
Marketwire Canada - Tue Jun 07, 5:00AM CDT
NORTHRIDGE, CA and PERTH, AUSTRALIA and CAMBRIDGE, UNITED KINGDOM--(Marketwired - Jun 7, 2016) - Avita Medical Limited (ASX: AVH) (OTCQX: AVMXY) has furthered its expansion into the Asian market with the appointment of a specialized wound care distributor for its products in Malaysia.
AVH: 6.47 (-0.09)
Clinical Study in UK to Evaluate ReGenerCell(TM) for Diabetic Foot Ulcer Treatment
Marketwired - Mon May 30, 9:11PM CDT
NORTHRIDGE, CA and PERTH, AUSTRALIA and CAMBRIDGE, UNITED KINGDOM--(Marketwired - May 30, 2016) - Avita Medical Ltd. (ASX: AVH) (OTCQX: AVMXY)
AVH: 6.47 (-0.09)
Avita's Novel ReNovaCell(TM) Technology Offers Key Advantages in Skin Repigmentation of Burn Scars, When Combined With Medical Needling
Marketwired - Mon May 09, 5:00AM CDT
Data Published in Peer-Reviewed Journal Burns
AVH: 6.47 (-0.09)
Research Confirms That ReCell(R) Reduces Long-Term Scarring and Itching Outcomes in Pediatric Burns Treatment
Marketwire Canada - Thu May 05, 7:37PM CDT
UK Study Results Presented at American Burn Association (ABA) Annual Meeting
AVH: 6.47 (-0.09)
Avita Medical's ReCell Technology Demonstrated at Vitiligo Conferences in China
Marketwired - Mon May 02, 9:41PM CDT
Avita Medical Limited (ASX: AVH) (OTCQX: AVMXY)
AVH: 6.47 (-0.09)
Regenerative Medicine Approach Delivers Healing and Cost Savings for Chronic Wounds
Marketwired - Sun May 01, 9:57PM CDT
Avita Medical (ASX: AVH) (OTCQX: AVMXY)
AVH: 6.47 (-0.09)